The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease
Coronary Heart Disease
About this trial
This is an interventional treatment trial for Coronary Heart Disease focused on measuring L-Citrulline malate,Coronary Heart Disease, Brachial Index
Eligibility Criteria
Inclusion Criteria:
1- patients with coronary heart disease without history of diabetes or any chronic disease 2- no myocardial infarction in last 6 months 3-ejection fraction more than 50% 4- please to recruit in the trial 5-no uncontrolled blood pressure 6- with stable condition when come to the clinic
Exclusion Criteria:
1- those who refuse to being in the trial 2- those which their total condition become worse 3- CCU admission as a result of being unstable 4- patients with chronic heart failure(CHF)
Sites / Locations
- National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Stimol, Brachial Index, Powder agent
Placebo, Brachial Index, Powder agent
L-Citrulline malate,1gr,twice a day,2weeks
Placebo,1gr,twice a day,2weeks